Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

NCT06948760 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DEVICE: Control-IQ insulin pump with Lyumjev insulin
DEVICE: Control-IQ insulin pump with Humalog or Novolog

Sponsor

Mark D. DeBoer, MD, MSc., MCR

Collaborators

[object Object]